FDA refuses Zogenix’s seizure drug Fintepla
The company did not submit certain non-clinical studies to allow the FDA to assess chronic administration of the drug.
Read More
Tag: childhood epilepsy
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
- Daratumumab becomes first oncology injectable approved for patient administration
- Laigo Bio completes final close of €17m seed financing round
